Israel Eyes Wall Street for $50B Defense IPO: Why Tel Aviv Isn't Enough
Israel is moving forward with plans to take two of its most prominent state-owned defense giants public — and it's looking across the Atlantic to do it. The Israeli government is preparing to list Israel Aerospace Industries (IAI) and Rafael Advanced Defense Systems on a major US exchange, with a delegation set to travel to the United States in mid-July 2026 to explore the feasibility of the listings.
The combined valuation of the two companies is staggering. IAI is currently valued at approximately $33.7 billion, while Rafael is estimated at around $20 billion, according to Bloomberg. The government is seeking to offload stakes of up to 30% in each firm, with officials aiming to finalize a deal before the end of the year.
But this isn't simply a story about raising capital. At the heart of the matter is a disclosure dilemma that has haunted IAI's privatization efforts for years. Both companies operate classified defense programs — including the globally recognized Arrow and Iron Dome anti-missile systems — and Israeli regulators have historically shown little willingness to grant exemptions when it comes to national security-related disclosures. That regulatory rigidity has been a key obstacle, having already delayed IAI's privatization for six years despite receiving government approval.
US regulators, by contrast, are viewed by Israeli officials as more open to accommodating national security concerns. A listing on the Nasdaq or New York Stock Exchange could also activate Israel's dual-listing framework, allowing both IAI and Rafael to trade simultaneously on the Tel Aviv Stock Exchange under foreign listing rules — a significant operational advantage.
During their US visit, Israeli officials plan to meet with investors, underwriters, and legal advisors to understand how American securities law intersects with the unique requirements of companies running sensitive government contracts. The delegation will also examine whether listing subsidiaries of IAI and Rafael independently could be a viable path, potentially sidestepping the parliamentary approval requirements tied to the parent entities.
The timing of the initiative adds significant pressure. A regulatory change that came into effect in March 2026 now mandates that directors and officers of foreign private issuers publicly disclose equity holdings and transactions in real time — a notable departure from previous standards that raises the bar for any overseas listing. Israel is wagering that negotiated national security exemptions will be sufficient to offset these heightened obligations.
Rafael faces an additional deadline: the company must secure government approval before parliament dissolves ahead of elections expected by late October 2026.
Both companies enter these discussions from a position of financial strength. IAI reported record 2025 revenues of $7.4 billion, a net profit of $712 million, and an order backlog that surpassed $30 billion for the first time in the company's history. Rafael similarly hit a milestone, with its backlog crossing $20 billion.
Despite these strong fundamentals, critical questions remain unanswered. No final decisions have been made regarding either the timing or the specific exchange for the listings. Whether US regulators will ultimately agree to the disclosure carve-outs that Israel is counting on remains uncertain — and that uncertainty could determine whether this landmark defense IPO makes it to Wall Street at all.
